Multiresistant Pseudomonas infection remains a problem in hospital practice. We report a case of pseudomonas peritonitis successfully treated by a combination of azlocillin and amikacin. This is the first case report of the intraperitoneal use of azlocillin.
KnotheH. Durch gramnegative Bakterien Ausgelbste Infektionen. Deutche Arzt1979; 7:51–54.
2.
WiseGillettAndrewsBedford. Activity of Azlocillin and Mexocillin against gram-negative organisms: Comparison with other penicillins. Antimicrob Agents Chemother1978; 13(4):559–565.
3.
SchachtPBruckHDyckaJHallmanRTettenbornD. Results of the clinical trial of Azlocillin. Acylureido-Penecillin. International Symposium Vienna 1979;188–193.
4.
Farrell, Wilks, Drasar. Synergy between Aminoglycoside and semi-synthetic penicillins against gentamicin resistant gram-negative rods. J Antimicrob Chemother1979; 5 (1): 23–29.
5.
KamptDSchurigRWeihermillerKSchachtP. Pharmacokinetics of Azlocillin and Mezlocillin in patients with chronic renal failure and haemodialysis or peritoneal dialysis. Acylureido-Penicillin International Symposium Vienna1979:53–56.
6.
MeyersRDLewisRPCarmaltE DuaneFinegoldSM. Amikacin therapy for serious gram-negative bacillary infections. Ann Intern Med1975; 83:790–800.
7.
SmithCRBanghnanKLEdwardsCQRodgersJFLietmenPS. Controlled comparison of Amikacin and Gentamicin. N Engl J Med1977; 296: 349–353.
